Find Faculty
Ron Do, PhD
img_Ron Do
PROFESSOR | Genetics and Genomic Sciences
212-241-6206
email
Research Topics
Atherosclerosis, Cardiovascular, Computational Biology, Epigenetics, Genetics, Genomics, Human Genetics and Genetic Disorders, Systems Biology
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]
Do Lab Description
Please see https://labs.icahn.mssm.edu/dolab/ for a description of the research performed in the Do Lab.

BSc, University of British Columbia

MSc, University of British Columbia

PhD, McGill University

Post-doc, Massachusetts General Hospital/Broad Institute/Harvard Medical School

Instructor, Harvard Medical School

2020

The Dr. Harold and Golden Lamport Clinical Research Award

Icahn School of Medicine at Mount Sinai

2010

Banting Fellowship

Canadian Institutes of Health Research

135
Publications

Selected Publications

Large-scale cross-ancestry genome-wide meta-analysis of serum urate. Chamlee Cho, Beomsu Kim, Dan Say Kim, Mi Yeong Hwang, Injeong Shim, Minku Song, Yeong Chan Lee, Sang Hyuk Jung, Sung Kweon Cho, Woong Yang Park, Woojae Myung, Bong Jo Kim, Ron Do, Hyon K. Choi, Tony R. Merriman, Young Jin Kim, Hong Hee Won. Nature Communications

Muesli Intake May Protect Against Coronary Artery Disease: Mendelian Randomization on 13 Dietary Traits. Joshua K. Park, Ben Omega Petrazzini, Shantanu Bafna, Áine Duffy, Iain S. Forrest, Ha My Vy, Carla Marquez-Luna, Marie Verbanck, Jagat Narula, Robert S. Rosenson, Daniel M. Jordan, Ghislain Rocheleau, Ron Do. JACC: Advances

Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes. Ha My T. Vy, Steven G. Coca, Ashwin Sawant, Ankit Sakhuja, Orlando M. Gutierrez, Richard Cooper, Ruth J.F. Loos, Carol R. Horowitz, Ron Do, Girish N. Nadkarni. Clinical Journal of the American Society of Nephrology

View All Publications

Annenberg Building Floor 18 Room 80B

1468 Madison Ave

New York, NY 10029

212-241-6206

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Do during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Pensieve Health
  • Variant Bio

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Pensieve Health

Founder/Co-Founder/Partner

  • Pensieve Health

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.